Local alopecia areata treatments are applied to or injected into the affected areas, while systemic treatments are taken by mouth and work throughout the body. Local treatment is commonly used for a few patches of hair loss, whereas systemic treatment may be considered when hair loss is widespread, severe, or progressing quickly. The best option depends on the extent of hair loss, its pattern, the person's age, and how the condition is changing.
What is the difference between local and systemic treatment?
Alopecia areata is an autoimmune condition in which the immune system mistakenly attacks hair follicles, interrupting normal hair growth. Treatment aims to reduce the effects of this immune activity and encourage hair regrowth.
The main difference between local and systemic treatment is where the medication acts.
- Local treatment: Medication is applied directly to affected skin or injected into the skin within a bald patch. It mainly targets the treated area.
- Systemic treatment: Medication enters the bloodstream and affects processes throughout the body. Many systemic treatments work by changing the immune response involved in alopecia areata.
For example, a corticosteroid cream applied to a bald patch is a local treatment. A corticosteroid tablet taken by mouth is a systemic treatment, even though both medicines belong to the same drug group.
According to the British Association of Dermatologists, treatment choices depend largely on how much hair has been lost. Some people with limited hair loss may not need medication immediately because hair can regrow without treatment.
Which local treatments are used for alopecia areata?
Local treatments are often considered when hair loss affects a small number of areas. They can be useful when the affected patches are accessible for direct application or injection.
1. Corticosteroid injections
Intralesional corticosteroid injections are among the commonly used treatments for limited patchy alopecia areata. Intralesional means that the medication is injected directly into the skin rather than taken by mouth.
A dermatologist usually uses a fine needle to inject a corticosteroid, often triamcinolone, into the affected patches. The medication helps reduce inflammation around the hair follicles and may allow hair to grow again.
In adults, injections are commonly repeated every four to six weeks, depending on the treatment plan and response. Some people begin to notice regrowth within a few months. These injections are particularly useful when there are only a few bald patches rather than widespread hair loss.
The American Academy of Dermatology identifies corticosteroid injections as an effective option for people with a few patches of alopecia areata. Its patient guidance notes that visible regrowth may begin within approximately three months when the treatment works.
Possible limitations and side effects include:
- Temporary discomfort or pain during injections.
- Thinning of the skin at the injection site.
- A small depression or dimple in the treated area.
- Potential eye-related complications when injections are given too close to the eyes or used excessively around the eyebrows.
Injections are therefore performed carefully, especially around the face and eyebrows. The dermatologist also decides when to stop repeating them, usually after sufficient regrowth or when further treatment is unlikely to help.
2. Topical corticosteroid creams and lotions
Topical corticosteroids are prescription medicines applied directly to bald patches. They may be available as creams, ointments, lotions, foams, or scalp solutions.
These medicines reduce inflammation in the treated skin. They are often considered when injections are unsuitable, when affected areas need treatment over a broader surface, or when treating children.
A dermatologist selects the strength, formulation, application schedule, and treatment duration according to the affected area and the person's age. Stronger preparations are not automatically better because prolonged or inappropriate use can cause skin-related side effects.
The British Association of Dermatologists describes corticosteroid creams and scalp applications as options for alopecia areata, with treatment courses commonly lasting around six weeks before reassessment or consideration of another course.
3. Contact immunotherapy
Contact immunotherapy is another treatment applied directly to the skin. It is generally considered for more extensive alopecia areata when ordinary local treatments have not provided sufficient improvement.
A dermatologist applies a chemical sensitizing agent, such as diphenylcyclopropenone, to the affected scalp. The treatment produces a controlled skin reaction. The aim is to modify the immune activity affecting the hair follicles.
Treatment is usually repeated at regular intervals in a specialist setting. It may cause itching, redness, blistering, or eczema-like reactions. Changes in skin pigmentation can also occur.
Although contact immunotherapy is applied locally, it may cover large areas of the scalp. This is an important distinction: local treatment does not always mean treatment for only one or two small patches.
4. Minoxidil as an additional treatment
Minoxidil is a topical medicine that may help support hair growth or maintain regrowth after another treatment has worked. It is sometimes added to a plan involving corticosteroids or other therapies.
However, minoxidil does not directly address the underlying immune activity responsible for alopecia areata. Evidence for its effectiveness when used alone in this condition is limited. It is therefore generally considered an additional treatment rather than a replacement for therapies that target the immune response.
Which systemic treatments are used for alopecia areata?
Systemic treatments are considered when hair loss involves larger areas, progresses rapidly, or has a substantial effect on the scalp or other hair-bearing parts of the body. These medicines can influence immune activity throughout the body rather than acting only where hair loss is visible.
1. Oral corticosteroids
Oral corticosteroids, such as prednisolone, are sometimes prescribed for rapidly progressing or more extensive alopecia areata. They reduce immune system activity and may help slow active hair loss while encouraging regrowth.
Unlike steroid injections, which target individual patches, oral corticosteroids affect the immune response throughout the body. They may be used as a short course, with the dose gradually reduced according to the treatment plan.
One important limitation is that hair loss can return after the medicine is reduced or stopped. Long-term use is generally avoided because corticosteroids can cause significant side effects, particularly when higher doses are needed.
Potential side effects include:
- Weight gain and increased appetite.
- Raised blood pressure.
- Increased blood sugar or diabetes.
- Mood changes and sleep disturbances.
- Stomach problems.
- Increased risk of osteoporosis and cataracts with prolonged use.
The British Association of Dermatologists notes that oral corticosteroids may help in moderate-to-severe cases, particularly when treatment begins early, but relapse after stopping treatment and the risk of side effects limit their use as a long-term option.
2. Oral JAK inhibitors
Janus kinase (JAK) inhibitors are targeted medicines that reduce activity in immune-signalling pathways involved in alopecia areata. They are taken by mouth and may be considered for severe or extensive hair loss.
Unlike corticosteroid injections, which treat specific patches, oral JAK inhibitors affect immune activity throughout the body. They are an important treatment option for some people with extensive disease.
Examples of JAK inhibitors used for alopecia areata include:
- Baricitinib: An oral JAK inhibitor used for severe alopecia areata in approved patient groups.
- Ritlecitinib: An oral medicine that targets JAK3 and TEC-family kinase pathways and is used for eligible patients with severe disease.
- Deuruxolitinib: An oral JAK inhibitor approved for adults with severe alopecia areata in the United States.
Approval rules, minimum ages, availability, and eligibility differ between countries. In the United States, the American Academy of Dermatology lists baricitinib and ritlecitinib for eligible patients aged 12 years and older, while deuruxolitinib is approved for adults with severe alopecia areata.
JAK inhibitors require careful medical assessment. Possible concerns include infections and other significant safety risks. Regulatory warnings about certain serious outcomes, including blood clots and cardiovascular events, have been issued for this class of medicines. The extent to which some of these risks apply specifically to people receiving JAK inhibitors for alopecia areata remains uncertain.
People considering these medicines should discuss their medical history, other medications, possible side effects, and the required follow-up with their dermatologist.
3. Other immune-suppressing medicines
Other systemic medicines may sometimes be considered when alopecia areata is extensive or has not responded adequately to other treatments. Examples include methotrexate, ciclosporin, azathioprine, and mycophenolate mofetil.
These medicines reduce immune system activity through different mechanisms. Some are used in other inflammatory or autoimmune conditions and may be prescribed for alopecia areata in selected cases.
However, evidence supporting their use in alopecia areata is more limited than for some established treatment options. They can also cause important side effects, so the decision involves weighing the possible benefit against the person's overall health and risk factors.
Systemic immunosuppressants are not usually the first choice for someone with only a few small patches of hair loss.
Local vs systemic alopecia areata treatment: side-by-side comparison
The following comparison highlights the main practical differences between the two approaches.
| Feature | Local treatment | Systemic treatment |
|---|---|---|
| How it works | Acts mainly on the treated skin or hair-loss patches. | Acts throughout the body, often by changing immune activity. |
| Common forms | Creams, lotions, scalp applications, and injections into affected skin. | Tablets or capsules taken by mouth. |
| Examples | Topical corticosteroids, intralesional corticosteroids, contact immunotherapy, and minoxidil as an additional treatment. | Oral corticosteroids, JAK inhibitors, methotrexate, and ciclosporin. |
| Common treatment setting | Often used for limited patches, although contact immunotherapy may cover extensive areas. | Considered for rapidly progressing, moderate-to-severe, or extensive disease. |
| Whole-body exposure | Generally less systemic exposure, depending on the medicine and how it is used. | Greater potential for effects throughout the body. |
| Main limitations | May not adequately manage widespread or rapidly progressing hair loss. Some treatments require repeated applications or injections. | Potentially more significant whole-body side effects and a need for closer medical follow-up. |
| Who may receive it? | Adults and children, depending on the medicine and affected area. | Eligible adults and, for certain medicines, adolescents. Age limits depend on the treatment. |
When is local treatment usually preferred?
Local treatment may be a suitable starting point when alopecia areata affects a small number of patches and there is no rapid progression. It allows a dermatologist to target the affected areas without immediately using medication that acts throughout the body.
It may be considered when:
- Hair loss is limited to a few small patches.
- The affected areas can be treated with creams, lotions, or injections.
- There is no rapid spread of hair loss.
- A person prefers to avoid systemic medication when an appropriate local option is available.
- A child needs treatment that can be applied directly to the scalp.
Observation without active medication may also be reasonable in selected cases. According to MedlinePlus, a service of the US National Library of Medicine, hair may regrow within a few months without treatment when alopecia areata is not widespread.
The possibility of natural regrowth is one reason dermatologists may recommend monitoring rather than starting medication immediately, particularly when hair loss is limited and has been present for a relatively short time.
When might systemic treatment be more appropriate?
Systemic treatment may be considered when local therapies are unlikely to cover the full extent of the condition or have not provided sufficient control.
Situations that may lead a dermatologist to discuss systemic treatment include:
- Hair loss affecting large areas of the scalp.
- Rapid development of new bald patches.
- Extensive loss involving the scalp, eyebrows, eyelashes, or body hair.
- Limited improvement despite an appropriate trial of local treatment.
- A substantial effect on daily life or emotional wellbeing.
Systemic treatment does not automatically become necessary whenever more than one patch appears. The pattern, extent, speed of progression, previous treatment response, and potential risks all matter. For example, someone with several stable patches may still be managed with local treatment, while someone with quickly progressing hair loss may need a broader treatment approach.
Can local and systemic treatments be used together?
Yes. Local and systemic treatments can sometimes be combined when a single approach does not address every treatment need.
For example, a dermatologist may prescribe an oral medicine to address widespread immune activity while also recommending a topical treatment for selected areas. Minoxidil may sometimes be added to support hair density or maintain regrowth.
Combination treatment is not necessary for everyone. Using several medicines can increase treatment complexity and may introduce additional side effects. The dermatologist considers the expected benefit, interactions, and safety of the complete treatment plan before recommending it.
How does age affect the choice of treatment?
Children and adults may receive different treatment plans. The child's age, amount of hair loss, treatment setting, and possible side effects influence the decision.
In younger children: Observation may be appropriate when hair loss is limited because spontaneous regrowth can occur. When treatment is needed, topical corticosteroids are commonly considered. Their dermatologist may also discuss minoxidil as an additional option in selected cases.
In older children and teenagers: More treatment options may become available depending on age and the extent of hair loss. Injections may be considered selectively, although discomfort can make them less suitable for some children. Certain oral JAK inhibitors are approved for eligible adolescents aged 12 years and older in some countries.
In adults: Local steroid injections are a commonly used option for limited patches. Systemic corticosteroids, JAK inhibitors, or other immune-suppressing medicines may be considered for more extensive disease, depending on the person's health and treatment eligibility.
Age limits are not identical for all medicines. A treatment approved for adults may not be suitable for a younger patient, even when the pattern of hair loss is similar.
What should be considered before choosing a treatment?
The choice between local and systemic treatment is not based on the number of bald patches alone. A dermatologist considers several factors to understand which approach is most suitable.
Extent and pattern of hair loss
The amount of hair affected is an important consideration. A few isolated patches may respond to local treatment, while extensive scalp or body hair loss may require a broader approach.
How quickly hair loss is progressing
Stable hair loss and rapidly developing patches may require different treatment strategies. Faster progression can make treatments that act throughout the body worth considering.
Previous treatment response
A dermatologist may review which treatments have already been tried, how consistently they were used, whether regrowth occurred, and whether new patches developed. This helps determine whether to continue, change, or combine treatments.
Other health conditions and medication risks
Medical history can influence treatment safety. For example, a history of recurrent infections or certain cardiovascular conditions may affect whether a particular systemic medicine is appropriate. Other prescribed medicines may also need to be considered.
Personal preferences and daily routine
Local injections may require repeated clinic visits, while topical treatments require consistent application at home. Oral medicines may be more convenient for some people but can involve additional monitoring and safety considerations.
Does local or systemic treatment provide more lasting hair regrowth?
Neither approach guarantees permanent regrowth. Some people respond well to treatment, while others experience incomplete improvement or further episodes of hair loss.
Local treatments can produce useful regrowth in affected patches, particularly when hair loss is limited. However, treating one patch does not necessarily prevent new patches from appearing elsewhere.
Systemic medicines can help some people with extensive disease, but improvement may require continued treatment. Hair loss can return after certain treatments are stopped or reduced. This is particularly relevant to oral corticosteroids, for which relapse after withdrawal is a recognised limitation.
Alopecia areata can also improve naturally, regardless of whether treatment is used. As a result, hair regrowth during treatment does not always mean that the condition will remain inactive.
What happens if treatment does not work?
If hair does not regrow as expected, the dermatologist may review the diagnosis, treatment duration, adherence, and pattern of hair loss. The next step may involve changing the local medicine, considering a different treatment, or discussing systemic options.
For someone already receiving systemic treatment, the dermatologist may reassess whether the medicine is providing enough benefit to justify continuing it. Side effects, changes in the extent of hair loss, and the person's treatment goals all contribute to this decision.
It is also important to review the emotional effect of hair loss. Supportive options such as wigs, head coverings, eyebrow cosmetics, or psychological support may help alongside medical treatment.
Which treatment approach is right for you?
Local treatment is often a practical first option for limited alopecia areata because it targets the affected skin and generally avoids the wider exposure associated with oral medicines. Systemic treatment becomes more relevant when hair loss is extensive, rapidly progressing, or not adequately controlled with local approaches.
There is no single treatment that works for everyone. A dermatologist can assess the pattern and extent of hair loss, the person's age, previous treatment response, medical history, and preferences before recommending a suitable plan. In some cases, careful observation is reasonable; in others, local and systemic treatments may be used together.